Cargando…
Complex polymeric nanomicelles co-delivering doxorubicin and dimethoxycurcumin for cancer chemotherapy
Combinational therapy is a new trend in medical sciences to achieve a maximum therapeutic response of the drugs with a comparatively low incidence of severe adverse effects. To overcome the challenges of conventional formulations for cancer chemotherapy, a polymer-based complex nanomicellar system,...
Autores principales: | Sohail, Muhammad, Yu, Bin, Sun, Zheng, Liu, Jiali, Li, Yanli, Zhao, Feng, Chen, Daquan, Yang, Xin, Xu, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135434/ https://www.ncbi.nlm.nih.gov/pubmed/35611890 http://dx.doi.org/10.1080/10717544.2022.2073403 |
Ejemplares similares
-
A Promising Anticancer Agent Dimethoxycurcumin: Aspects of Pharmacokinetics, Efficacy, Mechanism, and Nanoformulation for Drug Delivery
por: Sohail, Muhammad, et al.
Publicado: (2021) -
Preparation, characterization, in vivo pharmacokinetics, and biodistribution of polymeric micellar dimethoxycurcumin for tumor targeting
por: Liu, Hui, et al.
Publicado: (2015) -
BMI1 is downregulated by the natural compound curcumin, but not by bisdemethoxycurcumin and dimethoxycurcumin
por: Adeyeni, Temitope A., et al.
Publicado: (2016) -
Dual-responsive doxorubicin-loaded nanomicelles for enhanced cancer therapy
por: Zhang, Xinyi, et al.
Publicado: (2020) -
In vitro additive antitumor effects of dimethoxycurcumin and 5‐fluorouracil in colon cancer cells
por: Zhao, Huiying, et al.
Publicado: (2017)